Status:
RECRUITING
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Sepsis
Eligibility:
All Genders
1+ years
Brief Summary
Sepsis is a disruption of homeostasis in the human body in response to bloodstream infection and is associated with a high risk of mortality. Worldwide, sepsis is affecting approximately 30 million p...
Eligibility Criteria
Inclusion
- Adult or child patient
- Hospitalized in one of the departments registered with Hospices Civils de Lyon
- Showing signs of infection
- Confirmed by a 1st positive blood culture
- Patient or close relative (trustworthy person or family member) or holder of parental authority who has given his or her non-objection after receiving the information note
Exclusion
- Patients under court protection
- Patients under guardianship or curatorship
Key Trial Info
Start Date :
March 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
1372 Patients enrolled
Trial Details
Trial ID
NCT06219135
Start Date
March 21 2024
End Date
May 1 2026
Last Update
March 10 2025
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Femme Mère enfant Hospital
Bron, France, 69394
2
Femme Mère Enfant Hospital
Bron, France, 69394
3
Femme Mère enfant Hospital
Bron, France, 69394
4
Louis Pradel Hospital
Bron, France, 69394